Key considerations when evaluating technical suppliers
PCMG have invited ClinOne to join this VIRTUAL event to discuss the key considerations when evaluating technical suppliers. This online event will offer the following outputs:
Understand some of the different types of clinical technologies
Key items to consider when selecting and evaluating technical suppliers
Regulatory expectations/requirements
Understanding the interactions between different clinical systems
What should be included in contractual agreements
AGENDA OVERVIEW
14:00 – 14:05
Welcome and introductions
Lan Bandara, PCMG Committee Member & Director, Clinical Trial Supplies, Eisai
14:05 – 14:45
Keynote Presentation: “What a Difference a Year Makes: The Value, Challenges, and Lessons Learned from Rapid Technology Adoption”
Rob Bohacs, Co-Founder and CEO, ClinOne, Inc with Ryan O’Mara, Director Clinical Operations and Trial Innovations, Vigil Neuroscience
Rapid implementation due to the COVID catalyst – what did we learn from the sponsor side? (challenges of how to evaluate, qualify, audit vendors with new and sometimes untested technology)
Technology provider responsibilities – keeping promises (with this rapid adoption, what were some observed challenges and pitfalls from scaling up and what did we see with delivery?)
Conversation with Ryan O’Mara
The five essential capabilities every provider needs to have (Product Value, Globalization, Accurate Timelines, Regulatory Experience, Solution Delivery)
15:00 – 15:20
Q&A
15:20 – 15:40
Breakout discussions
Key questions in a RFI
How to compare different technologies providing the same solution